Michael Rohr

Michael represents growth stage technology and life sciences companies from inception to exit. Michael counsels these companies on their general corporate and strategic needs, as well as on fundraising and transactional matters. He also counsels venture capital and growth/private equity funds, corporate VCs and strategic acquirors on investment transactions and acquisitions.

Representative Transactions include:

Private

• Tectonic in its $80 million Series A financing
• General Catalyst in its investment in Eleanor Health's $50 million Series C financing
• General Catalyst in its investment in Olive's $51 million Seed Series financing
• Seismic Therapeutic in its $101 million Series A financing
• Zealand Pharma in its acquisition of Valeritas Holdings
• automotiveMastermind in its $45 million Series B financing and secondary tender offer
• Brightree sale to ResMed for $800 million
• Confidential unicorn technology company in its $1 billion+ Series D financing
• Frontline Technologies in its acquisition of School Improvement Networks and Prologic Technology Systems
• General Catalyst in its Series B investment in Index Systems
• Guidepost Growth Equity in its $60 million Series B investment in Lucid Holdings and secondary tender offer
• HighJump Software sale to Accellos (Accell-KKR) for $237.5 million
• Infraredx sale to Nipro Corporation
• ·nToggle in its Series A financing, Series A-1 financing and eventual sale to Rubicon Project
• Tarveda Therapeutics in its $30 million Series D financings
• Vesper Technologies in its $18 million Series A and $26 million Series B financings
• InAuth in its Series A-1 financing with American Express
• Avedro in its $32 million recapitalization and Series AA financing, Series BB financing and Series CC financing
• The Cambridge Incubator (CIC) in its reorganization and $59 million Series A financing
• RxAdvance in its secondary investment and tender offer, joint venture and subsequent Series A financing with Centene (CNC)
• CIMCON Lighting in its $16 million Series B financing
• Bessemer in its Series B investment in Toast
• Represented M33 Growth in multiple strategic growth equity investments/acquisitions, including Waterfield Energy Software, Titan Cloud Software and AssuriCare

Public

• Avedro in its $70 million US IPO
• Biodel in its acquisition of Albireo
• Jefferies in the $35.9 million follow-on offering by TechTarget
• NetScout Systems acquisition of Danaher Corporation's communications business unit for $2.6 billion 

Michael’s practice includes company and investor side representation on venture capital financings, growth equity transactions, secondary liquidity transactions and M&A.